Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Meletios Α. Dimopoulos(Korea University), Evangelos Terpos(National and Kapodistrian University of Athens), Efstathios Kastritis(National and Kapodistrian University of Athens), Jesús F. San Miguel(Clinica Universidad de Navarra), Mohamad Mohty(Sorbonne Université), Katja Weisel(Universität Hamburg), Brian G.M. Durie(Cedars-Sinai Medical Center), Laurent Garderet(Inserm), Heinz Ludwig(Wilhelminen Hospital), María‐Victoria Mateos(Hospital Clínico San Carlos), Alessandro Gozzetti(University of Siena), Joan Bladé(Hospital Clínic de Barcelona), Niels W.C.J. van de Donk(Oncode Institute), Ioannis Ntanasis‐Stathopoulos(National and Kapodistrian University of Athens), Meral Beksaç(Ankara University), Paul G. Richardson(Harvard University), Nikhil C. Munshi(Dana-Farber Cancer Institute), Joseph Mıkhael(Translational Genomics Research Institute), Ashraf Badros(University of Maryland, Baltimore), S. Vincent Rajkumar(WinnMed), Jens Hillengaß(Roswell Park Comprehensive Cancer Center), Giampaolo Merlini(University of Pavia), Frank Bridoux(Université de Poitiers), Simon J. Harrison(Peter MacCallum Cancer Centre), P. Joy Ho(The University of Sydney), Philippe Moreau(Centre National de la Recherche Scientifique), Nelson Leung(WinnMed)
Cited by 120
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k